Apollo Global Management, Inc. filed a Form 8-K with the SEC on August 11, 2026, disclosing that its subsidiary Athene Holding Ltd. published a presentation titled "Overview of Athene's Corporate Structure" on its investor relations website at ir.athene.com.
Quantum Corporation filed its quarterly report on Form 10-Q for the period ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 11, 2026, disclosing condensed consolidated financial statements and related management discussion for the first fiscal quarter of 2027.
Daedalus Special Acquisition Corp. filed its quarterly report on Form 10-Q with the SEC on August 11, 2026, covering the three and six months ended June 30, 2026, disclosing financial results and balance sheet details for the blank-check company listed on NASDAQ:DSAC.
Cohen Circle Acquisition Corp. II filed its Form 10-Q for the quarter ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting its financial results and balance sheet position as a blank check company operating under trust.
Karman Holdings Inc. filed its Form 10-Q with the SEC on August 11, 2026, covering the quarterly period ended June 30, 2026, disclosing revenue, earnings, and balance sheet results for the three and six months ended on that date.
Alamar Biosciences, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission, disclosing financial and operational information as a non-accelerated filer listed on NASDAQ:ALMR.
Shattuck Labs, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the Securities and Exchange Commission, with the report made available on August 11, 2026.
Twenty One Capital, Inc. filed its quarterly report on Form 10-Q with the SEC for the quarterly period ended June 30, 2026, disclosing condensed consolidated financial statements and related information as of that date.
Twenty One Capital, Inc. filed a Form 8-K with the SEC on August 11, 2026, disclosing that Chief Executive Officer Raphael Zagury issued a letter to shareholders on the same date, furnished under Regulation FD.
Upstream Bio, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.